The company is currently preparing for Phase III trials to further assess the efficacy and safety of the agent in identifying ...

has granted fast track designation for the development of Bracco Imaging's molecular imaging ultrasound contrast agent, BR55, to identify active bowel inflammation areas in Crohn's disease patients.

Bracco Imaging receives FDA Fast Track designation for BR55, ultrasound molecular imaging agent for the detection of active bowel inflammation in Crohn’s Disease. News release. Bracco Imaging.

Diagnosis of Crohn's disease (CD) is often challenging and ... computed tomographic enterography and intestinal ultrasound) and noninvasive markers of disease such as fecal calprotectin and ...

June 10, 2024 — Scientists have grown 'mini-guts' in the lab to help understand Crohn's disease, showing that 'switches' that modify DNA in gut cells play an ... Major Cause of Inflammatory ...

Let's dive deep into a topic that isn’t getting enough shine – Crohn's disease and how it's hitting the Black community.

The findings from the PROSPERO study reveal that multiple hospitalizations, long-term disease duration, prior surgeries, and factors like corticosteroid use and total parenteral nutrition ...

Gastrointestinal (GI) symptoms are the hallmark of Crohn’s disease, but this autoimmune condition can affect any part of the digestive system, including the mouth. Oral symptoms might even be th ...

Researchers have discovered that the disease causes changes in the immune system early in life, presumably even in newborns. These changes lead to frequent inflammation ... New Screening Device ...

Although gut microbiota and lipid metabolites have been suggested to be closely associated with type 2 diabetes mellitus (T2DM), the interactions between gut microbiota, ...